Home Stock

Stock Research: Sol-Gel Technologies

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Sol-Gel Technologies

NAQ:SLGL IL0011417206
8
  • Value
    18
  • Growth
    12
  • Safety
    Safety
    47
  • Combined
    10
  • Sentiment
    42
  • 360° View
    360° View
    8
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Sol-Gel Technologies Ltd is a clinical-stage dermatology company focused on developing and commercializing branded and generic topical drug products for skin diseases. The company's main businesses include developing products like twins, sirs-t, and vered, utilizing its proprietary silica-based microencapsulation technology. In the last fiscal year, the company had a market cap of $22 million, and a revenue of $12 million, with 34 employees.

more

ANALYSIS: With an Obermatt 360° View of 8 (better than 8% compared with alternatives), overall professional sentiment and financial characteristics for the stock Sol-Gel Technologies are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Sol-Gel Technologies. The consolidated Value Rank has a low rank of 18 which means that the share price of Sol-Gel Technologies is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 82% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 12, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 12% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 47, which means that the company has a riskier financing structure than 53% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 42, which means that professional investors are more pessimistic about the stock than for 58% of alternative investment opportunities. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Analyst Opinions
Country Israel
Industry Pharmaceuticals
Size X-Small
Website sol-gel.com
Index
NASDAQ
Sol-Gel Technologies stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 17-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
18 37 27 10
Growth
12 43 11 53
Safety
Safety
47 98 70 70
Sentiment
42 32 69 96
360° View
360° View
8 63 1 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
100 72 100 95
Opinions Change
3 50 50 50
Pro Holdings
n/a 4 4 60
Market Pulse
58 44 76 69
Sentiment
42 32 69 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
18 37 27 10
Growth
12 43 11 53
Safety Safety
47 98 70 70
Combined
10 83 27 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
5 38 3 13
Price vs. Earnings (P/E)
95 26 26 25
Price vs. Book (P/B)
10 91 84 27
Dividend Yield
1 1 1 1
Value
18 37 27 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
1 4 92 1
Profit Growth
17 94 6 89
Capital Growth
4 75 7 100
Stock Returns
98 4 7 16
Growth
12 43 11 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
87 100 100 100
Refinancing
32 98 95 76
Liquidity
16 1 9 9
Safety Safety
47 98 70 70

Similar Stocks

Discover high‑ranked alternatives to Sol-Gel Technologies and broaden your portfolio horizons.

Fresenius

GER:FRE
Country: Germany
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Strabag

VIE:STR
Country: Austria
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Faes Farma

MCE:FAE
Country: Spain
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Yara International

OSL:YAR
Country: Norway
Industry: Fertilizers & Agricultural Chemicals
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews